nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adjuvant chemotherapy for tumors of one centimeter or less: The law of diminishing returns
|
Soule, Sharon E. |
|
2001 |
3 |
6 |
p. 529-535 |
artikel |
2 |
Brain metastases: Biology and the role of the brain microenvironment
|
Puduvalli, Vinay K. |
|
2001 |
3 |
6 |
p. 467-475 |
artikel |
3 |
Brain metastases: Still an ‘Orphan’ disease?
|
Gilbert, Mark R. |
|
2001 |
3 |
6 |
p. 463-466 |
artikel |
4 |
Chemotherapy for metastatic tumors to the central nervous system
|
Conrad, Charles A. |
|
2001 |
3 |
6 |
p. 490-494 |
artikel |
5 |
Literature Alert
|
|
|
2001 |
3 |
6 |
p. 456-459 |
artikel |
6 |
Postmastectomy radiotherapy in women with breast cancer metastatic to one to three axillary lymph nodes
|
Sartor, Carolyn I. |
|
2000 |
3 |
6 |
p. 497-505 |
artikel |
7 |
Radiotherapy and radiosurgical management of brain metastases
|
Flickinger, John C. |
|
2001 |
3 |
6 |
p. 484-489 |
artikel |
8 |
Surgical management of brain metastases
|
Weinberg, Jeffrey S. |
|
2001 |
3 |
6 |
p. 476-483 |
artikel |
9 |
Targeting signal transduction
|
Bertino, Joseph R. |
|
2001 |
3 |
6 |
p. 453-454 |
artikel |
10 |
The role of adjuvant monoclonal antibody therapy for breast cancer: Rationale and new studies
|
Perez, Edith A. |
|
2001 |
3 |
6 |
p. 516-522 |
artikel |
11 |
The role of bisphosphonates as adjuvant therapy for breast cancer
|
Gralow, Julie R. |
|
2001 |
3 |
6 |
p. 506-515 |
artikel |
12 |
Web Alert
|
|
|
2001 |
3 |
6 |
p. 460 |
artikel |
13 |
What is the ideal duration of adjuvant therapy for primary breast cancer: Are four cycles of cyclophosphamide and doxorubicin enough?
|
Shulman, Lawrence N. |
|
2001 |
3 |
6 |
p. 523-528 |
artikel |